AIM ImmunoTech Inc
AIM - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.77M
Close$
$-0.29
280.9% downside
Current Fair Value
280.9% downsideOvervalued by 280.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.77 Million |
|---|---|
| Enterprise Value | $-6,828,483.00 |
| Earnings per Share | $-8.62 |
| Beta | 1.27 |
| Outstanding Shares | 17,118,695 |
Return
| Return on Equity | -184.27% |
|---|---|
| Return on Assets | -112.09% |
| Return on Invested Capital | -72.54% |
Valuation & Multiples
| P/E Ratio | -0.04 |
|---|---|
| PEG | -0.11 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -36.17 |
| Enterprise Value to EBIT | 0.61 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.09 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.37
Consensus analyst estimateRevenue Estimate
$100,000
Consensus analyst estimateNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
$-0.09
Consensus analyst estimateRevenue Estimate
$25,729
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.04%▲ 4.04% |
|---|---|
| Total Invested | $102,813 |
| Investors Holding | 18▲ 18.00% |
About AIM ImmunoTech Inc
CEO: Thomas Equels
